However, expression of PTPN11 was found to be relatively lesser in breast invasive carcinoma (BRCA), glioblastoma multiforme (GBM), kidney renal clear cell carcinoma (KIRC), LUAD, prostate adenocarcinoma (PRAD), thyroid carcinoma (THCA), and uterine corpus endometrial carcinoma (UCEC) compared to that of relating healthy tissues (Figure 1A). Here, PTPN11 is linked to uterine corpus endometrial carcinoma.